An antiglobulin enzyme-linked immunosorbent assay for rubella-specific IgG x and IgG 3 was adapted to measure antibody avidity by incorporating a mild protein denaturant, diethylamine (DEA), into the serum diluent. Sera were tested at varying dilutions, both with and without DEA, if they contained sufficient specific IgGj or IgG 3 . The optical density (OD) was measured and curves were plotted. The highest OD (7) was noted and halved (7/2). The distance between the OD curves at 7/2 was measured as the DEA shift value.
INTRODUCTION
Rubella reinfection is usually subclinical, and is diagnosed when it is concluded from consideration of results of previous testing, vaccination history and serological findings that the antibody response demonstrated occurred in a person who had previously been infected with rubella as a consequence of natural infection or immunization. As reinfection in pregnancy is considered currently to present minimal risk to the fetus (Morgan-Capner, 1986) , distinction from asymptomatic primary rubella, which carries a significant risk to the fetus (Cradock-Watson et al. 1981) , is of critical importance.
As specific IgM can be detected both in primary rubella and rubella reinfection, the serological differentiation can no longer be based solely on its detection (Morgan-Capner et al. 1985) . We have previously investigated the rubella-specific IgG subclass profile in primary rubella and rubella reinfection (Thomas & MorganCapner, 1988 ). Although such testing may provide helpful information as specific IgG 3 may not be detectable in reinfection, it cannot be used reliably to distinguish the two. We have investigated, therefore, a further serological approach, the functional affinity (avidity) of rubella-specific IgG x and IgG 3 .
The sum of the attractive and repulsive forces between a monovalent antibody and a monovalent antigen or hapten is the affinity of the reaction. Each IgG molecule has two antigen-binding sites, and viruses (or viruses crudely prepared as antigens) are multivalent antigens. The multivalent binding is termed the functional affinity or avidity (Roitt, Brostoff & Male, 1986) . The avidity is thus the function which applies to an antibody population directed against a virus. An antibody population produced in response to an antigen contains antibodies of many avidities. It has been shown that antibodies produced early after infection or antigenic challenge are generally of lower avidity than those produced later (Eisen & Siskind, 1964; Siskind & Benecerraf, 1969; Rodkey & Freeman. 1970 : Devey et al. 1988 ). Therefore it should be possible to distinguish between primary rubella and rubella reinfection on the basis of specific antibody avidity. Inouye et al. (1984) and Rousseau & Hedman (1988) showed that differences could be demonstrated for avidity of rubella-specific IgG between patients with primary rubella, a small number of cases with rubella reinfection and those who had had rubella in the distant past. They used protein denaturants, guanidine hydrochloride and urea respectively, to demonstrate differences in avidity, and this is essentially the same approach used by Devey et al. (1988) , who used diethylamine instead to look at the development of avidity of antibodies produced against tetanus toxoid. We have used the latter method, and report the results on large groups of sera from cases of primary rubella and rubella reinfection.
MATERIALS AND METHODS

Sera
The following sera were tested. (a) Twenty-four sera from cases of rubella in the distant past. All contained rubella-specific IgG detectable by radial haemolysis (Kurtz et al. 1980) . All contained rubella-specific IgG x at a concentration > 30 arbitrary units (a.u.) (Thomas & Morgan-Capner, 1988) .
(b) Sixty-six sera from 53 cases of primary rubella. The date of onset was known for 35 cases from whom 42 sera were obtained. Fifty-nine aof the 66 sera contained sufficient rubella-specific IgGj (> 30 a.u.) for the avidity studies to be performed, and 48 contained sufficient rubella-specific IgG 3 (> 30 a.u.). Seven sera did not contain sufficient IgGj for the avidity studies; four were undated sera and three were taken soon after onset of the illness (< 21 days). All seven contained low concentrations of specific IgG t . Eighteen sera from cases of primary rubella had insufficient specific IgG 3 for avidity studies, 4 were sera from children with hereditary spherocytosis and aplastic crisis, 4 were not dated. 5 were taken early and 5 were taken late after onset of symptoms. All sera contained specific IgM except three: two taken 1 day and one taken more than 2 months after onset.
(r) Eleven sera taken from six cases of confirmed clinically-apparent rubella reinfection. The date of onset of illness was known for five cases. All sera contained sufficient rubella-specific IgG x for the avidity studies, but only two contained sufficient specific lgG 3 . Eight of the sera contained specific IgM detectable at a concentration greater than 3 a.u. by IgM antibody-capture radioimmunoassay MACRIA (Mortimer et al. 1981) .
(d) Sixty-four sera from 39 cases of confirmed asymptomatic rubella reinfection. All sera contained sufficient specific IgG x for the avidity studies, but only 10 had sufficient specific IgG 3 . The date of contact was known for 30 cases, and 21 sera contained detectable specific IgM at a concentration greater than 3 a.u.
Isotype-specific avidity ELISA
Microtitre plates were coated with rubella antigen as described previously (Thomas & Morgan-Capner. 1988 ). The treatment of serum with the protein denaturant diethylamine (DEA) was an adaptation of the method described by Devey et al. (1988) . Sera were diluted initially 1 in 10 in phosphate-buffered saline containing 0-05% Tween 20 (PBST) and 2% normal goat serum (2% XGS/ PBST). They were then diluted in 50 ji\ volumes in antigen-coated wells in twofold dilutions from 1 in 20 to 1 in 2560 in parallel in 2% XGS/PBST and in 2% XGS/ PBST containing 35 mM diethylamine (Analar) (2% XGS/PBST/DEA). The plates were incubated in a sealed moist box for 1 h at room temperature before washing six times with PBST. The remainder of the assay (monoclonal anti-IgG subclass antibodies, peroxidase-conjugated anti-mouse immunoglobulin and substrate) was carried out as described previously (Thomas & Morgan-Capner, 1988) . The reaction was stopped by the addition of 4N-H 2 S0 4 before the maximum optical density (OD) reached 2-00. Optical density at 490 nm was measured using an MR 600 spectrophotometer (Dynatec Laboratories Ltd, Billinghurst, Sussex) and the OD plotted against the log 10 of the reciprocal of the serum dilution (Fig. 1) . Two titration curves, with and without DEA, were plotted for each serum. The highest OD value (V) was noted and halved (V/2). At the OD V/2 the distance between the two curves was measured. This distance was the DEA shift value and was therefore equal to the log 10 of the reciprocal serum dilution in 2 % XGS/PBST at V/2 minus the log 10 of the reciprocal serum dilution in 2 % XBS/ PBST/DEA at V/2 (Fig. 1) .
RESULTS
Specific IgG 1 shift values
With sera taken from cases of rubella in the distant past, the mean shift value was 0-45, with a standard deviation of 0-15 and a range of 0-2-0-6 (Table 1) .
The mean DEA shift value for the 59 sera from cases of primary rubella was 0-91. with a standard deviation of 0-24 and a range of 045-1-3 (Table 1 ). Fig. 2 shows the relation between DEA shift value and time after onset of symptoms. It shows that within the first 28 days after onset the DEA shift value was alwayŝ 0-8 and then started to decline. Three sera taken on day 28 gave lower values (0-75. 0'75. 0-53) and another on day 33 gave a value of 0-48. Amongst the sera of unknown date of illness. 17 had DEA shift values less than 0-9. Four of these sera were from two children with an aplastic crisis and hereditary spherocytosis and were strongly positive for parvovirus B19-specific igM confirming recent parvovirus B19 infection. All four had low concentrations of rubella-specific IgM. suggesting either primary rubella some while before or cross-reacting IgM with rubella having occurred in the distant past. The serological profile and clinical details of the other 13 sera from 10 patients suggested that they were all collected some while after the rubelliform illness, with most being investigated for persisting polyarthralgia. Date of onset/ contact not known Fig. 2 . DEA shift values for specific IgGj with sera from primary rubella and rubella reinfection. Sera from cases of rubella and symptomatic reinfection are recorded in relation to days after onset of illness. Sera from cases of asymptomatic reinfection are recorded against days after contact with an index case of rubella. # , Primary rubella; x . asymptomatic reinfection; S, symptomatic reinfection.
All 75 sera from the clinically apparent and subclinical reinfections contained sufficient specific IgG s for avidity studies. The mean DEA shift value was 0-41, with a standard deviation of (M2 and a range of (M-O65 (Table 1) . The relation between DEA shift value and contact (asymptomatic reinfection) or onset of illness (symptomatic reinfection) is shown in Fig. 2 . The DEA shift values do not change with time and are lower than those seen in primary rubella.
Specific IgG 3 shift values
The mean DEA shift value for the 48 sera from cases of primary rubella was 1-05, with a standard deviation of 0-31 and a range of 0-45-1-6 (Table 1) . The relation to days after onset of rash is shown in Fig. 3 , with all sera collected within the first 30 days after onset of illness giving DEA shift values ^ 0-7. Of the 16 Date of onset/ contact not known Fig. 3 . DEA shift values for specific IgG 3 with sera from primary rubella and rubella reinfection. Sera from cases of rubella and symptomatic reinfection are recorded in relation to days after onset of illness. Sera from cases of asymptomatic reinfection are recorded against days after contact with an index case of rubella. 0 . Primary rubella: x . asymptomatic reinfection; S, symptomatic reinfection. undated sera, 3 gave values < 0-7 and the serological profile and clinical details suggested that these sera were taken some time after the onset of the illness.
Twelve of the 75 sera from cases of reinfection contained sufficient concentrations of specific IgG 3 for avidity studies. Six were dated and all had DEA shift values < 055 (Fig. 3) . The maximum DEA shift value seen with the undated sera from asymptomatic reinfection was 06, with two sera from one case of symptomatic reinfection having values of O7 and 0 -8. This patient gave low DEA shift values, however, for specific IgGj (0-45 and 0-3), but did have high concentrations of specific IgG 3 (> 100 a.u.) for reinfection. The mean DEA shift value of specific IgG 3 for cases of reinfection was 0-48. with a standard deviation of 017 and a range of 0-25-0-8 (Table 1) .
DISCUSSION
The adaptation to measure avidity of the antiglobulin ELISA for rubellaspecific IgG subclass antibody was straightforward, using the protein denaturant diethylamine as described by Devey et al. (1988) . We examined the avidity of specific IgGi and IgG 3 separately, as we had recently developed these assays and had demonstrated their validity (Thomas & Morgan-Capner. 1988 ). However, the method described here should be readily adaptable to an antiglobulin ELISA for total rubella-specific IgG or antibody, and we have confirmed this with a few sera.
In primary rubella the avidity of rubella-specific IgG x and IgG 3 increased with time after the onset of illness. Two sera taken 28 and 33 days after the stated date of onset of primary rubella had low DEA shift values. However, consideration of the concentrations of specific IgM and the given history suggests that these sera were possibly taken later after the infection than was stated. All sera taken within 1 month of onset of primary rubella gave DEA shift values of ^ 0-8 for specific IgGj and ^ O7 for specific IgG 3 . This contrasted with the values obtained for specific IgGj for sera from cases of rubella in the distant past, which all gave a DEA shift value < 0-6. Unfortunately we had no sera from cases of rubella in the distant past which had sufficient IgG 3 to determine avidity.
The avidity of specific IgG x and IgG 3 antibody did not increase with time after contact or illness for the cases of reinfection. No serum from a case of reinfection had a DEA shift value > 0-65 for rubella-specific IgG 1; a marked difference from the results for sera known to have been taken soon after onset of primary rubella. From these results, if due account is taken of the date of the serum in relation to illness or contact, the determination of specific igGj subclass avidity is a reliable approach to distinguishing recent primary rubella from rubella reinfection. However, it would not be surprising if occasional exceptions are seen, should further sera be tested by this method. It is unlikely that any approach will always be able to distinguish serologically with certainty between reinfection and primary rubella if only late sera are available.
This study demonstrates that specific IgG 3 also differs in avidity between sera taken soon after primary infection from those taken late after primary infection, that is, following a reinfection. All sera taken within a month of primary infection had DEA shift values of ^0 7 compared with sera from reinfection which, with two exceptions, had DEA shift values ^ 0-6. The exceptions were two sera from one case of symptomatic reinfection, which had DEA shift values of 0-7 and 0-8. These sera gave low specific IgGj DEA shift values, compatible with reinfection, and specific IgM concentrations that were low (6*5, 5-1 a.u.). However, the sera had unusually high concentrations of specific IgG 3 (both ^ 100 a.u.) for reinfection (Thomas & Morgan-Capner, 1988) . No pre-contact or earlier serum was available, but the patient had been immunized against rubella 9 years previously. There was no precise date of contact given. Lehtonen & Meurman (1982) used a complicated mathematical approach to determine rubella-specific IgG avidity and concluded that high-avidity antibody developed more slowly than total antibody after primary infection. They contrasted this with their findings for sera from seven clinically apparent reinfections in immunized women, where high-avidity antibody developed at a faster rate. Inoye et al. (1984) and Rousseau & Hedman (1988) used more simple approaches but investigated only very few cases of reinfection. Our findings agree with their reports. Inoye et al. (1984) also examined and compared sera taken at various times after rotavirus infection and demonstrated changing avidity. Thus this approach may not only be of value in distinguishing primary rubella from reinfection but also is of potential value in the serological diagnosis of other infections.
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